Publication
Impact of Time‐to‐Surgery on Outcomes of Patients Undergoing Curative‐Intent Liver Resection for BCLC‐0, A and B Hepatocellular Carcinoma
dc.contributor.author | Tsilimigras, DI | |
dc.contributor.author | Hyer, JM | |
dc.contributor.author | Diaz, A | |
dc.contributor.author | Moris, D | |
dc.contributor.author | Bagante, F | |
dc.contributor.author | Ratti, F | |
dc.contributor.author | Pinto Marques, H | |
dc.contributor.author | Soubrane, O | |
dc.contributor.author | Lam, V | |
dc.contributor.author | Poultsides, GA | |
dc.contributor.author | Popescu, I | |
dc.contributor.author | Alexandrescu, S | |
dc.contributor.author | Martel, G | |
dc.contributor.author | Workneh, A | |
dc.contributor.author | Guglielmi, A | |
dc.contributor.author | Hugh, T | |
dc.contributor.author | Aldrighetti, L | |
dc.contributor.author | Endo, I | |
dc.contributor.author | Pawlik, TM | |
dc.date.accessioned | 2023-01-31T10:46:39Z | |
dc.date.available | 2023-01-31T10:46:39Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Background: The impact of a prolonged time-to-surgery (TTS) among patients with resectable hepatocellular carcinoma (HCC) is not well defined. Methods: Patients who underwent curative-intent hepatectomy for BCLC-0, A and B HCC between 2000 and 2017 were identified using a multi-institutional database. The impact of prolonged TTS on overall survival (OS) and disease-free survival (DFS) was examined. Results: Among 775 patients who underwent resection for HCC, 537 (69.3%) had early surgery (TTS < 90 days) and 238 (30.7%) patients had a delayed surgery (TTS ≥ 90 days). Patient- and tumor-related characteristics were similar between the two groups except for a higher proportion of patients undergoing major liver resection in the early surgery group (31.3% vs. 23.8%, p = .04). The percentage of patients with delayed surgery varied from 8.8% to 59.1% among different centers (p < .001). Patients with TTS < 90 days had similar 5-year OS (63.7% vs. 64.9; p = .79) and 5-year DFS (33.5% vs. 42.4; p = .20) with that of patients with TTS ≥ 90 days. On multivariable analysis, delayed surgery was not associated with neither worse OS (BCLC-0/A: adjusted hazards ratio [aHR] = 0.90; 95% confidence interval [CI]: 0.65-1.25 and BCLC-B: aHR = 0.72; 95%CI: 0.30-1.74) nor DFS (BCLC-0/A: aHR = 0.78; 95%CI: 0.60-1.01 and BCLC-B: aHR = 0.67; 95% CI: 0.36-1.25). Conclusion: Approximately one in three patients diagnosed with resectable HCC had a prolonged TTS. Delayed surgery was not associated with worse outcomes among patients with resectable HCC. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | J Surg Oncol . 2021 Feb;123(2):381-388 | pt_PT |
dc.identifier.doi | 10.1002/jso.26297 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/4368 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.subject | Aged | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Carcinoma, Hepatocellular / mortality* | pt_PT |
dc.subject | HCC CHBPT | pt_PT |
dc.subject | Carcinoma, Hepatocellular / pathology | |
dc.subject | Carcinoma, Hepatocellular / surgery | |
dc.subject | Databases, Factual | |
dc.subject | Follow-Up Studies | |
dc.subject | Hepatectomy / mortality* | |
dc.subject | Liver Neoplasms / mortality* | |
dc.subject | Liver Neoplasms / pathology | |
dc.subject | Liver Neoplasms / surgery | |
dc.subject | Middle Aged | |
dc.subject | Neoplasm Staging | |
dc.subject | Retrospective Studies | |
dc.subject | Survival Rate | |
dc.subject | Time-to-Treatment / statistics & numerical data* | |
dc.title | Impact of Time‐to‐Surgery on Outcomes of Patients Undergoing Curative‐Intent Liver Resection for BCLC‐0, A and B Hepatocellular Carcinoma | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 388 | pt_PT |
oaire.citation.issue | 2 | pt_PT |
oaire.citation.startPage | 381 | pt_PT |
oaire.citation.title | Journal of Surgical Oncology | pt_PT |
oaire.citation.volume | 123 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |